Status:
TERMINATED
Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Kidney Transplant
Eligibility:
All Genders
13+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.
Eligibility Criteria
Inclusion
- Dialysis patients who will be receiving their first kidney transplant
- Weight over 88 pounds (lbs.)
Exclusion
- Very high cholesterol levels
- Obesity
- Organ donor over 65 years of age if living; over 60 years of age if cadaveric.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00137345
Start Date
June 1 2005
End Date
August 1 2006
Last Update
February 8 2013
Active Locations (82)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego, California, United States, 92123
2
San Francisco, California, United States, 94143
3
Denver, Colorado, United States, 80262
4
New Haven, Connecticut, United States, 06520